Related content

Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure

By Gelbaya Tarek   Vitthala Srisailesh   Nardo Luciano   Seif Morad  

Gynecological Endocrinology, Vol. 27, Iss. 1, 2011-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy

By Chen Rong   Zhou Huimei   Zhang Yiwen  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 216-218

Informa Healthcare

Access to resources Recommend Favorite

Serum anti-Müllerian hormone expression in women with premature ovarian failure

By Méduri G.   Massin N.   Bachelot A.   Fiori O.   Kuttenn F.   Misrahi M.   Touraine P.  

Human Reproduction, Vol. 22, Iss. 1, 2007-01 ,pp. : 117-123

Oxford University Press

Access to resources Recommend Favorite

Genetics. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women

By Murray Anna   Webb James   MacSwiney Felicity   Shipley Emma L.   Morton Newton E.  

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1217-1218

Oxford University Press

Access to resources Recommend Favorite

Chromosomal abnormalities in women with premature ovarian failure

By Artini Paolo Giovanni   Ruggiero Maria   Papini Francesca   Valentino Valeria   Uccelli Alessia   Cela Vito   Genazzani Andrea Riccardo  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 717-724

Informa Healthcare

Access to resources Recommend Favorite